ID
27670
Descripción
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977
Palabras clave
Versiones (2)
- 9/11/17 9/11/17 -
- 26/11/17 26/11/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
26 de noviembre de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909
Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909
Descripción
Previous Clinical Trial Participation
Alias
- UMLS CUI-1
- C2348568
Descripción
The REDUCE 4 Year Contact is either: a) a REDUCE 4 Year clinic visit for subjects on treatment (Visit 10), or b) a REDUCE 4 Year clinic visit for subjects in Prostate Cancer Follow-Up (Visit 10P), or c) a 4 Year phone call for subjects in Phone Follow-Up
Tipo de datos
date
Alias
- UMLS CUI [1]
- C1320303
Descripción
Date Investigational Product Stopped
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0457454
Descripción
previous diagnosis of prostate cancer
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0332132
- UMLS CUI [1,2]
- C0600139
Descripción
date of biopsy
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0005558
Similar models
Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909
C0750480 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
C0600139 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])